Cargando…

Responder Analysis of a Multicomponent Non-Pharmacological Intervention (MAKS) for People With Cognitive Impairment in the German Day-Care Study (DeTaMAKS)

Background: Multicomponent non-pharmacological therapies have been shown to be effective at reducing cognitive symptoms and slowing deterioration in abilities to perform activities of daily living (ADL) in individuals with cognitive impairment. However, little is known about response rates and predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luttenberger, Katharina, Graessel, Elmar, Behrndt, Elisa-Marie, Özbe, Dominik, Donath, Carolin, Scheel, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712159/ https://www.ncbi.nlm.nih.gov/pubmed/31496961 http://dx.doi.org/10.3389/fpsyt.2019.00587

Ejemplares similares

The German day-care study: multicomponent non-drug therapy for people with cognitive impairment in day-care centres supplemented with caregiver counselling (DeTaMAKS) – study protocol of a cluster-randomised controlled trial
por: Behrndt, Elisa-Marie, et al.
Publicado: (2017)

Cost-effectiveness of a non-pharmacological treatment vs. “care as usual” in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controlled DeTaMAKS-trial
por: Steinbeisser, Kathrin, et al.
Publicado: (2020)

The MAKS-s study: multicomponent non-pharmacological intervention for people with severe dementia in inpatient care – study protocol of a randomised controlled trial
por: Diehl, Kristina, et al.
Publicado: (2020)

Can brief telephone interventions reduce caregiver burden and depression in caregivers of people with cognitive impairment? - long-term results of the German day-care study (RCT)
por: Donath, Carolin, et al.
Publicado: (2019)

Immediate Intervention Effects of Standardized Multicomponent Group Interventions on People with Cognitive Impairment: A Systematic Review
por: Özbe, Dominik, et al.
Publicado: (2019)

Non-pharmacological, psychosocial MAKS-s intervention for people with severe dementia in nursing homes: results of a cluster-randomised trial
por: Kratzer, André, et al.
Publicado: (2022)

Coordinated Regulation of Protoperithecium Development by MAP Kinases MAK-1 and MAK-2 in Neurospora crassa
por: Lan, Nan, et al.
Publicado: (2021)

Predictors of falls and hospital admissions in people with cognitive impairment in day-care: role of multimorbidity, polypharmacy, and potentially inappropriate medication
por: Scheel, Jennifer, et al.
Publicado: (2022)

Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomzied, controlled trial
por: Graessel, Elmar, et al.
Publicado: (2011)

Brief telephone counselling is effective for caregivers who do not experience any major life events – caregiver-related outcomes of the German day-care study
por: Behrndt, Elisa-Marie, et al.
Publicado: (2019)

MAK-4 and -5 supplemented diet inhibits liver carcinogenesis in mice
por: Penza, Marialetizia, et al.
Publicado: (2007)

Identification and Characterization of MicroRNAs in Ginkgo biloba var. epiphylla Mak
por: Zhang, Qian, et al.
Publicado: (2015)

Hunk/Mak-v is a negative regulator of intestinal cell proliferation
por: Reed, Karen R, et al.
Publicado: (2015)

From the T-cell receptor to cancer therapy: an interview with Tak W. Mak
por: Mak, Tak W.
Publicado: (2020)

DYF-5/MAK–dependent phosphorylation promotes ciliary tubulin unloading
por: Jiang, Xuguang, et al.
Publicado: (2022)

Day care for dementia patients from a family caregiver's point of view: A questionnaire study on expected quality and predictors of utilisation - Part II
por: Donath, Carolin, et al.
Publicado: (2011)

Regulation of cilium length and intraflagellar transport by the MAP kinases MAK, MRK, and MOK
por: Jansen, G, et al.
Publicado: (2012)

The MAK16 Gene of Entamoeba histolytica and Its Identification in Isolates from Patients
por: Crisóstomo-Vázquez, María del Pilar, et al.
Publicado: (2014)

Oxyfunctionalization of pyridine derivatives using whole cells of Burkholderia sp. MAK1
por: Stankevičiūtė, Jonita, et al.
Publicado: (2016)

MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors
por: Hora, Manuel, et al.
Publicado: (2017)

Plastome of mycoheterotrophic Burmannia itoana Mak. (Burmanniaceae) exhibits extensive degradation and distinct rearrangements
por: Li, Xiaojuan, et al.
Publicado: (2019)

Human NAA30 can rescue yeast mak3∆ mutant growth phenotypes
por: Drazic, Adrian, et al.
Publicado: (2021)

Distinct Expression Patterns of ICK/MAK/MOK Protein Kinases in the Intestine Implicate Functional Diversity
por: Chen, Tufeng, et al.
Publicado: (2013)

Efficient In Silico Identification of a Common Insertion in the MAK Gene which Causes Retinitis Pigmentosa
por: Bujakowska, Kinga M., et al.
Publicado: (2015)

Phosphatidic acid-mediated binding and mammalian cell internalization of the Vibrio cholerae cytotoxin MakA
por: Nadeem, Aftab, et al.
Publicado: (2021)

From board to bedside – training the communication competences of medical students with role plays
por: Luttenberger, Katharina, et al.
Publicado: (2014)

Assessment of the Toxicity and the Stability of Saeng Mak San by Using Repeated Intravenous Injections in Sprague-Dawley Rats
por: Lee, Hwa-Young, et al.
Publicado: (2016)

Development and biological characterization of a clinical gene transfer vector for the treatment of MAK-associated retinitis pigmentosa
por: Tucker, Budd A., et al.
Publicado: (2021)

Protein-lipid interaction at low pH induces oligomerization of the MakA cytotoxin from Vibrio cholerae
por: Nadeem, Aftab, et al.
Publicado: (2022)

V. cholerae MakA is a cholesterol-binding pore-forming toxin that induces non-canonical autophagy
por: Jia, Xiaotong, et al.
Publicado: (2022)

Eating while intoxicated: characterizing the molecular mechanism behind V. cholerae toxin MakA-regulated autophagy
por: Corkery, Dale P., et al.
Publicado: (2022)

Predictors of institutionalization in users of day care facilities with mild cognitive impairment to moderate dementia
por: Spiegl, Klara, et al.
Publicado: (2021)

2642. Multipathogen Antigen Test Kit (MAK-5) – Distribution and Frequency of Viral Respiratory Diseases in Germany among Volunteers in the VACCELERATE Registry
por: Nacov, Julia A, et al.
Publicado: (2023)

Identification of Nedd4 E3 Ubiquitin Ligase as a Binding Partner and Regulator of MAK-V Protein Kinase
por: Kalinichenko, Svetlana V., et al.
Publicado: (2012)

The NDR Kinase Scaffold HYM1/MO25 Is Essential for MAK2 MAP Kinase Signaling in Neurospora crassa
por: Dettmann, Anne, et al.
Publicado: (2012)

Agitation and aggression in people living with dementia and mild cognitive impairment in shared-housing arrangements – validation of a German version of the Cohen-Mansfield Agitation Inventory-Short Form (CMAI-SF)
por: Kratzer, André, et al.
Publicado: (2023)

A grander challenge: the case of how Makerere University College of Health Sciences (MakCHS) contributes to health outcomes in Africa
por: Pariyo, George, et al.
Publicado: (2011)

Utilization and uptake of the UpToDate clinical decision support tool at the Makerere University College of Health Sciences (MakCHS), Uganda
por: Kinengyere, Alison Annet, et al.
Publicado: (2021)

The GUL-1 Protein Binds Multiple RNAs Involved in Cell Wall Remodeling and Affects the MAK-1 Pathway in Neurospora crassa
por: Herold, Inbal, et al.
Publicado: (2021)

Downregulation of mapk/mak/mrk overlapping kinase 1 in peripheral blood mononuclear cells of pediatric patients with type 1 diabetes mellitus
por: Sopić, Miron, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_06cunl891gsvnj939usqgtf5eq